Overview
Julie Wolf holds a Ph.D. in Microbiology, Immunology, and Cancer Biology from the University of Minnesota [11] and a Bachelor of Science in Microbiology from the University of Michigan [10]. Wolf served as a post-doctoral researcher at Albert Einstein College of Medicine from 2010 to 2015 [9], then worked in science communications roles at the American Society for Microbiology as a Features Editor and Science Communications Specialist from 2015 to 2020 [7][8]. Wolf subsequently held positions at SOSV as Communications Director and Chief Science Officer of IndieBio NY between 2021 and 2022 [5][6]. Wolf has worked at 2048 Ventures as Principal from 2022 to 2024 [4] and currently serves as Partner [1][3]. Wolf's stated focus involves using science to build emerging technologies, coaching founders, and expanding access to opportunity [2].
Profile introduction
Using science to build the technologies of tomorrow. Coaching brilliant founders to reach their potential. Adding more chairs to the table. Favorite descriptor: capable.
Career history
- PartnerApr 2024 to present2048 Ventures
- PrincipalMar 2022 to Apr 20242048 Ventures
- Chief Science Officer, IndieBio NYAug 2021 to Feb 2022SOSV
- Communications DirectorMar 2020 to Feb 2022SOSV
- Science Communications SpecialistOct 2015 to Feb 2020American Society for Microbiology
- Features EditorJun 2015 to Feb 2020American Society of Microbiology
- Post-doctoral researcherJun 2010 to Jun 2015Albert Einstein College of Medicine
Education
Bachelor of Science (B.S.), MicrobiologyUniversity of Michigan
Doctor of Philosophy (PhD), Microbiology, Immunology, and Cancer BiologyUniversity of Minnesota
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.